journal
https://read.qxmd.com/read/38358621/predictive-value-of-tumor-infiltrating-lymphocytes-and-ki-67-for-pathological-response-to-total-neoadjuvant-therapy-in-rectal-cancer
#21
JOURNAL ARTICLE
Amrallah Mohammed, Adel Bakry, Shimaa Gharieb, Amira Hanna, Ahmed Obaya, Waleed Abdelhady, Abdelrahman Metwalli
PURPOSE: Patients with locally advanced rectal cancer (LARC) who underwent total neoadjuvant therapy (TNT) showed an increase in the percentage of complete pathological response (pCR). The purpose of this study was to determine the correlation between Ki-67, tumor-infiltrating lymphocytes (TIL), and TNT in LARC patients. METHOD: In total, one hundred fifty-nine patients with LARC were included in this prospective study. The international working group was used to categorize the TIL into three groups based on the percentage and density of staining: group 0 (0-10%), group 1 (11-59%), and group 2 (≥ 60%)...
February 15, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38353901/role-of-preoperative-radiation-therapy-for-resectable-gastric-cancer
#22
REVIEW
Grace Lee, Matthew R Strickland, Jennifer Y Wo
PURPOSE: While surgery is the primary curative treatment for resectable gastric and gastroesophageal junction (GEJ) cancer, rates of locoregional and distant recurrence remain high with surgery alone, especially in more advanced disease. Multimodal approaches with perioperative therapy including chemotherapy and/or radiation therapy (RT) have thus evolved as ways to reduce the rates of disease recurrence and improve survival outcomes. This review article provides a comprehensive literature review on the role of preoperative RT for resectable gastric and GEJ cancer...
February 14, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38351391/patient-perceptions-of-care-coordination-during-neoadjuvant-therapy-for-gastrointestinal-cancers-a-mixed-methods-analysis
#23
JOURNAL ARTICLE
Natalie M Bath, Marilly Palettas, Lena Stevens, Angela Sarna, Aslam Ejaz, Alex Kim, Timothy M Pawlik, Jordan M Cloyd
PURPOSE: Effective cancer care coordination (CCC) is an integral component of health care delivery and critical to achieving optimal oncologic outcomes. Neoadjuvant therapy (NT), the delivery of multimodality therapy prior to surgery, is inherently complex and multidisciplinary, but CCC during NT is poorly understood. The objective of this study was to characterize patient perceptions of CCC during NT using a mixed methods approach. METHODS: This study is a cross-sectional analysis of patients with gastrointestinal cancers receiving NT who participated in a prospective longitudinal cohort study evaluating their real-time experience using a customized smartphone application...
February 14, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38347342/patterns-of-failure-following-preoperative-chemotherapy-and-stereotactic-body-radiation-therapy-and-resection-for-patients-with-borderline-resectable-or-locally-advanced-pancreatic-cancer
#24
JOURNAL ARTICLE
Nicole Libbey, Lindsey Gallagher, Jonathan Cantalino, Benjamin A Weinberg, Marcus S Noel, Aiwu R He, Pejman Radkani, John L Marshall, Louis M Weiner, Patrick G Jackson, Thomas M Fishbein, Emily R Winslow, Nadim Haddad, Abdul Rashid, Keith R Unger
BACKGROUND: The role of neoadjuvant stereotactic body radiation therapy (SBRT) in the treatment of pancreatic adenocarcinoma (PDAC) is controversial and the optimal target volumes and dose-fractionation are unclear. The aim of this study is to report on treatment outcomes and patterns of failure of patients with borderline resectable (BL) or locally advanced (LA) pancreatic cancer following preoperative chemotherapy and SBRT. METHODS: We conducted a single-institution, retrospective study of patients with BL or LA PDAC...
February 13, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38342837/clinical-effect-of-tumor-specific-total-nutrients-in-patients-with-adjuvant-chemotherapy-after-radical-gastric-cancer-resection-a-randomized-controlled-trial
#25
JOURNAL ARTICLE
Xiumei Hua, Yang Liu, Yaqing Zhou
BACKGROUND: In this study, we combined adjuvant chemotherapy after radical gastric cancer resection with tumor-specific total nutrient therapy to analyze how it affects the nutritional state and immune function of the patient. METHOD: We collected data from 106 patients having undergone adjuvant chemotherapy after radical gastric cancer resection between January 2020 and December 2021. We divided the patients into experimental and control groups (with 53 cases in each group) through single-blinded simple randomization using a random number table and the sealed envelope system...
February 11, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38324136/primary-pancreatic-gist-a-single-centre-case-series-and-systematic-review-of-literature
#26
REVIEW
Vipul Gupta, Amit Chopde, Vikram Chaudhari, Munita Bal, Shailesh V Shrikhande, Manish S Bhandare
PURPOSE: GISTs arising from organs outside GI tract are defined as extragastrointestinal GISTs (EGIST). The majority of EGISTs arise from small intestinal mesentry, mesocolon, omentum, retroperitoneum, abdominal wall, liver and pancreas with pancreas comprising less than 5% of it. Due to limited data, it is unknown if the results of GIST can be generalised for EGISTs. We thereby present the largest single-centre case series of primary pancreatic GIST so far with review of existing literature...
February 7, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38319559/real-life-data-and-outcome-of-folfirinox-use-in-metastatic-pancreatic-cancer-patients-in-general-hospitals-in-the-netherlands
#27
JOURNAL ARTICLE
B C M Haberkorn, L Hoogendijk, O S Loosveld, A M J Thijs, J Verstijnen
INTRODUCTION: Pancreatic cancer is one of the five most common causes of cancer mortality in developed countries. In patients with metastatic disease, the most frequent treatment used is FOLFIRINOX, which is associated with moderate toxicity which could influence quality of life. The efficacy of FOLFIRINOX in a general population in the Netherlands has not been subject of research before, and therefore, this research has been set up in order to investigate what the real-life benefits of FOLFIRINOX are in a population with metastatic pancreatic cancer (mPC) treated in three general hospitals in the Netherlands...
February 6, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38315331/efficacy-of-cisplatin-containing-chemotherapy-regimens-in-patients-of-pancreatic-ductal-adenocarcinoma-a-systematic-review-and-meta-analysis
#28
REVIEW
Obaid Ur Rehman, Eeshal Fatima, Zain Ali Nadeem, Arish Azeem, Jatin Motwani, Habiba Imran, Hadia Mehboob, Alishba Khan, Omer Usman
BACKGROUND: The relative success of cisplatin-based chemotherapy regimens for PDAC in clinical trials warrants a review of the literature to assess the cumulative results. This study aims to assess the efficacy of cisplatin-containing regimens for PDAC in terms of survival and response outcomes using a systematic review and proportional meta-analysis. METHODS: In this study, an electronic search was conducted on PubMed, Cochrane Library, Scopus, and Google Scholar to find relevant literature...
February 5, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38315330/effect-of-preoperative-body-mass-index-on-postoperative-and-long-term-outcomes-in-an-east-indian-gastric-cancer-cohort
#29
JOURNAL ARTICLE
Dillip Kumar Muduly, Lalchhandami Colney, Madhabananda Kar, Mohammed Imaduddin, Susama Patra, Mahesh Sultania, Sudhakar G, Phanindra Kumar Swain, Biswajit Sahoo, Sudipta Mohakud, Hemanta Kumar Nayak, Manas Kumar Panigrahi
BACKGROUND: Gastric cancer is a global health concern with varying clinical outcomes. This study aims to investigate the influence of preoperative Body Mass Index (BMI) on survival in patients who underwent curative resection for gastric cancer in Eastern India. METHODS: Data from a prospectively maintained Surgical Oncology database were analysed for patients who underwent curative resection for primary gastric adenocarcinoma between May 2016 and March 2022. Patients with incomplete data were excluded...
February 5, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38308686/treatment-response-to-neoadjuvant-therapy-in-squamous-esophageal-cancer-correlation-between-metabolic-response-and-histopathology
#30
JOURNAL ARTICLE
Abdeali Saif Arif Kaderi, Jiwnani Sabita, Virendra Kumar Tiwari, Akash Pawar, Devayani Niyogi
PURPOSE: Esophageal cancer is among the leading causes of cancer-related mortality worldwide. Patients presenting with localized and loco-regionally advanced cancer without distant metastases have reasonable survival with multimodality management. Adequate and comprehensive staging is the backbone for proper selection of patients fit for curative treatment. Positron emission tomography (PET) in combination with contrast-enhanced computed tomography (CECT) is utilized as the standard staging modality...
February 3, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38289406/short-term-and-long-term-outcomes-after-laparoscopic-surgery-for-pathological-stage-t4a-and-t4b-colon-cancer
#31
JOURNAL ARTICLE
Yasuhiro Ishiyama, Yasumitsu Hirano, Hiroto Tanaka, Takatsugu Fujii, Naoto Okazaki, Chikashi Hiranuma, Katsuya Deguchi
No abstract text is available yet for this article.
January 30, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38280175/recurrence-pattern-treatment-modalities-and-prognostic-factors-after-definitive-chemoradiotherapy-for-recurrent-esophageal-cancer
#32
JOURNAL ARTICLE
Keiko Akahane, Shogo Hatanaka, Masahiro Kawahara, Masashi Endo, Yukiko Fukuda, Kohei Okada, Kazunari Ogawa, Satoru Takahashi, Michiko Nakamura, Masaaki Saito, Noriko Oyama-Manabe, Katsuyuki Shirai
BACKGROUND: Recurrent esophageal cancer (EC) has a poor prognosis. However, the recurrence patterns and therapeutic outcomes after definitive chemoradiotherapy (CRT) are not fully understood. We analyzed survival and prognostic factors associated with post-definitive CRT recurrent EC. METHODS: We retrospectively reviewed 71 consecutive patients with post-definitive CRT EC recurrence between 2008 and 2021 at our institution. Recurrence was locoregional, distant, and combined in 42 (59%), 18 (25%), and 11 (16%) patients, respectively...
January 27, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38280174/current-and-future-biomarkers-in-esophagogastric-adenocarcinoma
#33
REVIEW
Ryan Sappenfield, Eric Mehlhaff, Devon Miller, Johnathan E Ebben, Nataliya V Uboha
PURPOSE: Biomarker-based therapies have shown improved patient outcomes across various cancer types. The purpose of this review to summarize our knowledge of current and future biomarkers in esophagogastric adenocarcinoma (EGA). METHODS: In this publication, we will review current standard biomarkers in patients with upper GI cancers. We will also discuss novel biomarkers that are under investigations and their associated therapies that are currently in clinical trials...
January 27, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38280173/high-bile-titer-and-high-bile-to-serum-ratio-of-cyfra-21%C3%A2-%C3%A2-1-reliably-discriminate-malignant-biliary-obstruction-caused-by-cholangiocarcinoma
#34
JOURNAL ARTICLE
Jiancong Chen, Jiahua Liang, Borui Xu, Jianbo Liang, Mingjian Ma, Zicheng Wang, Guangyan Zeng, Qiongcong Xu, Lijian Liang, Jiaming Lai, Li Huang
INTRODUCTION: Previously we demonstrated that elevated serum CYFRA 21 - 1 is a reliable diagnostic and prognostic biomarker for biliary tract cancers. This study aims to explore the diagnostic performance of bile CYFRA 21 - 1 (bCYFRA 21 - 1) in discriminating malignant biliary obstruction (MBO) caused by cholangiocarcinoma (CCA). METHODS: 77 CCA patients ((17 intrahepatic CCA (iCCA), 49 perihilar CCA (pCCA) and 11 distal CCA (dCCA)) and 43 benign patients with biliary obstruction were enrolled...
January 27, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38277055/regional-therapy-approaches-for-gastric-cancer-with-limited-peritoneal-disease
#35
REVIEW
Amy Y Li, Shaina Sedighim, Fatemeh Tajik, Aaqil M Khan, Vinodh K Radhakrishnan, Farshid Dayyani, Maheswari Senthil
PURPOSE: Despite advances in systemic therapy, outcomes of patients with gastric cancer (GC) peritoneal carcinomatosis (PC) remain poor, in part because of poor penetrance of systemic therapy into peritoneal metastasis due to the plasma-peritoneal barrier and anarchic intra-tumoral circulation. Hence, regional treatment approach with administration of chemotherapy directly into the peritoneal cavity (intraperitoneal, IP) under various conditions, combined with or without cytoreductive surgery (CRS) has remained an area of significant research interest...
January 26, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38265570/burden-of-stomach-cancer-incidence-mortality-disability-adjusted-life-years-and-risk-factors-in-204-countries-1990-2019-an-examination-of-global-burden-of-disease-2019
#36
JOURNAL ARTICLE
Rajesh Sharma
BACKGROUND: Stomach cancer is a global health problem and is one of the leading causes of cancer deaths worldwide. This study investigates the spatial and temporal patterns of stomach cancer burden in 204 countries in the last three decades. DATA AND METHODS: The estimates of stomach cancer burden and its risk factors were obtained from the Global Burden of Disease (GBD) 2019 study, covering the years 1990 to 2019, across 204 countries within 21 world regions...
January 24, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38252186/association-of-methylenetetrahydrofolate-reductase-rs1801133-gene-polymorphism-with-cancer-risk-and-septin-9-methylation-in-patients-with-colorectal-cancer
#37
JOURNAL ARTICLE
Yafei Huang, Ting Su, Qiuting Duan, Xiangcong Wei, Xin Fan, Jinxiu Wan, Luping Liu, Ziqin Dian, Guiqian Zhang, Yi Sun, Tao Zhou, Ya Xu
PURPOSE: Colorectal cancer (CRC) is one of the most common malignancies, with a high incidence and mortality worldwide. Methylated Septin 9 (mSEPT9) has been used clinically as an auxiliary tool for CRC screening. The aim of the present study was to investigate the association of the methylenetetrahydrofolate reductase (MTHFR) rs1801133 polymorphism with the risk of CRC and the methylation status of Septin 9 in CRC. METHODS: Information of 540 patients with a confirmed diagnosis of CRC and with a physical examination were utilized to assess the association of the MTHFR rs1801133 polymorphism with CRC and the methylation of SEPT9...
January 22, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38240910/the-impact-of-dietary-factors-on-the-relief-of-bowel-dysfunction-among-patients-with-rectal-cancer-after-the-sphincter-saving-surgery-a-prospective-cohort-study
#38
JOURNAL ARTICLE
Wen Liu, Hai Ou Xia
PURPOSE: The study aims at exploring the impact of dietary intake on the relief of bowel dysfunction among patients with rectal cancer after the sphincter-saving surgery. METHODS: A prospective cohort design was used. A total of 299 patients were followed up at a tertiary hospital in East China between April 2020 and July 2021. Postoperative food intake was assessed with a food frequency questionnaire, and bowel dysfunction was assessed with Memorial Sloan Kettering Cancer Center's bowel function scale...
January 19, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38236375/simultaneous-integrated-boost-sib-versus-sequential-boost-in-anal-cancer-patients-a-single-center-experience
#39
JOURNAL ARTICLE
Divya Khosla, Rakesh Kapoor, Treshita Dey, Vaishali Kataria, Ranjit Singh, Divyesh Kumar, Arun Singh Oinam, Rajesh Gupta, Surinder Singh Rana, Jimil Shah, Harjeet Singh, Santhosh Irrinki, Renu Madan
PURPOSE: Concurrent chemoradiation is the standard of care for the treatment of anal cancer. Radiation can be delivered by sequential or simultaneous integrated boost (SIB) approach. The present study was conducted to compare the treatment outcomes and toxicity profile of patients with anal cancer treated with sequential boost and SIB approach. METHODS: A single-institution retrospective analysis of patients with squamous cell carcinoma of the anal canal treated between 2019 and 2022 with radical chemoradiation was performed...
January 18, 2024: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/38231290/perioperative-or-postoperative-probiotics-reduce-treatment-related-complications-in-adult-colorectal-cancer-patients-undergoing-surgery-a-systematic-review-and-meta-analysis
#40
JOURNAL ARTICLE
Jorge Eduardo Persson, Patricia Viana, Marina Persson, Jessica H Relvas, Lucineia G Danielski
PURPOSE: This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to assess the efficacy of perioperative or postoperative probiotics as a therapeutic approach for managing colorectal cancer treatment-related complications in patients undergoing surgery, with or without adjuvant therapy. METHODS: MEDLINE, Embase, and Scopus databases were searched. RESULTS: Ten RCTs with 1276 patients were included. There was a significant decrease in the incidence of diarrhea (odds ratio (OR) 0...
January 17, 2024: Journal of Gastrointestinal Cancer
journal
journal
42083
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.